Ondine is developing non-antibiotic therapies for the treatment of abroad spectrum of bacterial, fungal and viral infections. The Company isfocused on developing and commercializing leading edge products utilizingits patented light-activated technology. Photodisinfection providesbroad-spectrum antimicrobial efficacy without encouraging the formation andspread of antibiotic resistance. The Company is based in Vancouver, BritishColumbia, Canada, with a research and development laboratory in Bothell,Washington, USA, and an international office in St. Michael, Barbados.